Search
Feed aggregator
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Ma...
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Ma... 6/11/2024
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis 6/11/2024
Sage’s Dalzanemdor Shows Effect in Huntington’s Study, Analysts Say Results ‘Underwhelming’
Sage’s Dalzanemdor Shows Effect in Huntington’s Study, Analysts Say Results ‘Underwhelming’ 6/11/2024
Stada Bags European Rights from Alvotech to Biosimilar of Amgen Blockbusters
Stada Bags European Rights from Alvotech to Biosimilar of Amgen Blockbusters 6/11/2024
GSK Appeals Delaware Court’s Decision in Zantac Cases as Plaintiff Drops Lawsuit
GSK Appeals Delaware Court’s Decision in Zantac Cases as Plaintiff Drops Lawsuit 6/11/2024
Lilly Sees More Zepbound Out-of-Pocket Payments as Obesity Pill Nears Phase III Readout
Lilly Sees More Zepbound Out-of-Pocket Payments as Obesity Pill Nears Phase III Readout 6/11/2024
Top 5 Companies Hiring in San Diego
Top 5 Companies Hiring in San Diego 4/11/2024
VC Firm Flagship Raises $3.6B to Create, Support 25 ‘Breakthrough’ Companies
VC Firm Flagship Raises $3.6B to Create, Support 25 ‘Breakthrough’ Companies 7/10/2024
FDA Approves Atopic Dermatitis Label Expansion for Arcutis’ Zoryve Cream
FDA Approves Atopic Dermatitis Label Expansion for Arcutis’ Zoryve Cream 7/10/2024
Amylyx Pivots to GLP-1 Space, Acquires Phase III-Ready Asset from Eiger
Amylyx Pivots to GLP-1 Space, Acquires Phase III-Ready Asset from Eiger 7/10/2024
Alnylam Could Challenge Pfizer in ATTR-CM But Experts Want Full Data
Alnylam Could Challenge Pfizer in ATTR-CM But Experts Want Full Data 7/10/2024
Lilly’s I&I Play, ADC Investment and GLP-1 Momentum Persists
Lilly’s I&I Play, ADC Investment and GLP-1 Momentum Persists 7/10/2024
Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors
Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors 7/10/2024
Interius Gets Go-Ahead for Phase I Trial of In Vivo CAR-T Therapy in Australia
Interius Gets Go-Ahead for Phase I Trial of In Vivo CAR-T Therapy in Australia 7/10/2024
Why Is Antimicrobial Resistance Not Getting Much Attention from Biopharma?
Why Is Antimicrobial Resistance Not Getting Much Attention from Biopharma? 7/10/2024
Opinion: To Realize AI’s Benefits, Don’t Lose Sight of Fundamentals
Opinion: To Realize AI’s Benefits, Don’t Lose Sight of Fundamentals 7/10/2024
Adcomm Votes Unanimously for Lilly’s Alzheimer’s Treatment Donanemab
Adcomm Votes Unanimously for Lilly’s Alzheimer’s Treatment Donanemab 6/10/2024
Moderna’s COVID-Flu Combo Shot Beats Separate Vaccines in Phase III Study
Moderna’s COVID-Flu Combo Shot Beats Separate Vaccines in Phase III Study 6/10/2024
Alumis Files for IPO to Fund Phase III Trials of Potential Rival Drug to BMS’ Sotyktu
Alumis Files for IPO to Fund Phase III Trials of Potential Rival Drug to BMS’ Sotyktu 6/10/2024
Pfizer’s Paxlovid Ineffective Against Long COVID Using 15-Day Regimen: Study
Pfizer’s Paxlovid Ineffective Against Long COVID Using 15-Day Regimen: Study 6/10/2024
World Pharma News
- Scientists achieve record-breaking growth in miniature, functional liver models
- Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease
- Potential treatment for Parkinson's using investigational cell therapy shows early promise
- Researchers develop an LSD analogue with potential for treating schizophrenia
- The gut health benefits of sauerkraut